The 2023 International Conference on Newborn Sequencing (ICoNS) will be cohosted with Genomics England and held October 5 – 6, 2023 at the prestigious Royal Institution in London!

ICoNS 2023 will deliver two days of lectures and panel discussions on the technology of newborn genomic sequencing, implementation science, public health, ethics, equity and patient experience.

ICoNS 2023 is hosted by the International Consortium on Newborn Sequencing, an alliance of genomic scientists and stakeholders who share a vision of responsibly implementing newborn sequencing to predict treatable disease in babies and intervene before symptoms begin. 

This event will focus on the rapidly evolving field of precision oncology, including new diagnostic and therapeutic modalities, regulatory and reimbursement trends, and implementation challenges.

PMLS Precision Oncology 2023 will bring together key stakeholders to discuss strategies and best practices for implementing molecularly guided cancer care. Thought leaders from pharmaceutical and biotech firms, leading cancer centers, and the research community will share real-world experiences in delivering precision oncology to patient populations.